subscribeSubscribe
RBobay Pharma boosts CRDMO offerings with Cytiva`s FlexFactory platform

RBobay Pharma boosts CRDMO offerings with Cytiva`s FlexFactory platform
BIOSPECTRUM ASIA
09 May 2024
Share Share
Asahi Kasei & Axolabs partner to accelerate oligonucleotide therapeutics dvp

Asahi Kasei & Axolabs partner to accelerate oligonucleotide therapeutics dvp
INDINPHARMAPOST
11 Apr 2024
Share Share
Elena Zakharova Wins Cancer Drug Discovery Research Award

Elena Zakharova Wins Cancer Drug Discovery Research Award
PRESS RELEASE
15 Nov 2023
Share Share
Intellegens, CPI Awarded Innovate UK Grant for Oligonucleotide Therapeutics

Intellegens, CPI Awarded Innovate UK Grant for Oligonucleotide Therapeutics
CONTRACT PHARMA
30 Aug 2023
Share Share
EUROAPI to acquire BianoGMP to strengthen its CDMO expertise in the high-growth oligonucleotide market

EUROAPI to acquire BianoGMP to strengthen its CDMO expertise in the high-growth oligonucleotide market
PRESS RELEASE
30 Aug 2023
Share Share
Alloy Launches Proprietary AntiClastic™ Antisense Oligonucleotide Platform

Alloy Launches Proprietary AntiClastic™ Antisense Oligonucleotide Platform
BUSINESSWIRE
28 Jun 2023
Share Share
FDA blocks PepGen`s attempt to get 2nd oligonucleotide to clinic

FDA blocks PepGen`s attempt to get 2nd oligonucleotide to clinic
James Waldron FIERCE BIOTECH
31 May 2023
Share Share
PepGen tumbles after FDA hold notice on myotonic dystrophy study

PepGen tumbles after FDA hold notice on myotonic dystrophy study
BIOSPACE
31 May 2023
Share Share
Purification – A Bottleneck For Large-Scale Manufacturing Oligonucleotide API

Purification – A Bottleneck For Large-Scale Manufacturing Oligonucleotide API

PRESS RELEASE
12 May 2023
Share Share
Avidity Receives FDA Orphan Drug Designation for AOC 1020 to treat FSHD

Avidity Receives FDA Orphan Drug Designation for AOC 1020 to treat FSHD
PR NEWSWIRE
15 Feb 2023
Share Share